Moreover, in animal models of breast and lung cancers, the production of CXCR1/2 agonists by tumor cells was associated with high NET levels in the tumors, and NET levels were decreased after CXCR1/2 blockade. The gene discussed is CXCR1; the disease is lung carcinoma.